| |
| |
|
| Insider
Information: |
Chin Richard |
| Relationship: |
Director |
| City: |
Waltham, |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
423,413 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$148,321 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
423,413 |
|
|
| Total
Value |
$148,321 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mateon Therapeutics Inc |
MATN |
President and CEO, Dir... |
2008-01-11 |
392,074 |
2005-08-24 |
0 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Chief Executive Office... |
2021-08-27 |
0 |
2021-08-27 |
0 |
Premium* |
|
|
SELLAS Life Sciences Group Inc |
SLS |
Director |
2017-10-10 |
31,339 |
2014-01-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-30 |
4 |
OE |
$0.72 |
$57,250 |
D/D |
75,000 |
75,000 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-23 |
4 |
D |
$4.93 |
$64,894 |
D/D |
(13,163) |
1,968,353 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
President and CEO |
• • – |
2006-08-01 |
4 |
B |
$3.28 |
$65,950 |
D/D |
20,000 |
60,000 |
2.81 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-08-27 |
4 |
D |
$9.25 |
$74,000 |
I/I |
(8,000) |
0 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2020-01-23 |
4 |
D |
$9.66 |
$83,511 |
D/D |
(8,645) |
1,939,205 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2019-01-23 |
4 |
D |
$9.95 |
$85,984 |
D/D |
(8,646) |
1,921,957 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-22 |
4 |
D |
$4.93 |
$97,338 |
D/D |
(19,744) |
1,981,516 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2017-06-22 |
4 |
AS |
$7.75 |
$100,750 |
D/D |
(13,000) |
2,310,546 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-01-17 |
4 |
D |
$4.95 |
$104,584 |
D/D |
(21,128) |
1,963,760 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-01-23 |
4 |
D |
$9.15 |
$104,996 |
D/D |
(11,475) |
2,286,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2017-07-03 |
4 |
AS |
$8.26 |
$107,380 |
D/D |
(13,000) |
2,297,546 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
PRESIDENT AND CEO |
• • • |
2018-09-05 |
4 |
AS |
$14.69 |
$111,644 |
D/D |
(7,600) |
2,066,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2020-01-22 |
4 |
D |
$9.88 |
$114,677 |
D/D |
(11,607) |
1,947,850 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-05-30 |
4 |
AS |
$10.00 |
$126,100 |
D/D |
(12,610) |
2,226,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • • |
2019-01-22 |
4 |
D |
$10.12 |
$131,236 |
D/D |
(12,968) |
1,930,603 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-04-02 |
4 |
AS |
$8.39 |
$167,800 |
D/D |
(20,000) |
2,266,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-05-01 |
4 |
AS |
$9.05 |
$181,000 |
D/D |
(20,000) |
2,246,071 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
President and CEO |
• • – |
2006-09-15 |
4 |
B |
$4.02 |
$185,837 |
D/D |
45,464 |
105,464 |
2.81 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-02-12 |
4 |
OE |
$1.18 |
$297,625 |
D/D |
187,500 |
187,500 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-07-02 |
4 |
AS |
$9.18 |
$367,080 |
D/D |
(40,000) |
1,894,271 |
0 |
% |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-06-16 |
4 |
AS |
$9.18 |
$367,268 |
D/D |
(40,000) |
1,934,271 |
0 |
% |
|
| KIN |
Kindred Biosciences, Inc. |
Chief Executive Officer |
• • – |
2021-08-02 |
4 |
AS |
$9.21 |
$368,240 |
D/D |
(40,000) |
1,534,271 |
0 |
% |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-06-01 |
4 |
AS |
$10.13 |
$405,200 |
D/D |
(40,000) |
2,186,071 |
0 |
- |
|
| KIN |
Kindred Biosciences, Inc. |
President and CEO |
• • • |
2018-07-02 |
4 |
AS |
$10.28 |
$411,200 |
D/D |
(40,000) |
2,146,071 |
0 |
- |
|
| SLS |
SELLAS Life Sciences Grou... |
Director |
– • – |
2014-01-30 |
4 |
S |
$5.57 |
$418,755 |
D/D |
(75,000) |
0 |
0 |
- |
|
58 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
